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ABSTRACT
Lethal lesions after ionizing radiation are thought to be
mainly unrepaired or misrepaired DNA double-strand
breaks, ultimately leading to lethal chromosome
aberrations. However, studies with radioprotectors
and repair inhibitors indicate that single-strand breaks,
damaged nucleotides or abasic sites can also influence
cell survival. This paper reports on studies to further
define the role of base damage and base excision repair
on the radiosensitivity of human cells. We retrovirally
transduced human tumor cells with a dominant nega-
tive form of DNA polymerase β, comprising the 14 kDa
DNA-binding domain of DNA polymerase β but lacking
polymerase function. Radiosensitization of two human
carcinoma cell lines, A549 and SQD9, was observed,
achieving dose enhancement factors of 1.5–1.7.
Sensitization was dependent on expression level of the
dominant negative and was seen in both single cell
clones and in unselected virally transduced popula-
tions. Sensitization was not due to changes in cell cycle
distribution. Little or no sensitization was seen in
G1-enriched populations, indicating cell cycle specifi-
city for the observed sensitization. These results
contrast with the lack of effect seen in DNA polymerase
β knockout cells, suggesting that polDN also inhibits
the long patch, DNA polymerase β-independent repair
pathway. These data demonstrate an important role for
BER in determining sensitivity to ionizing radiation and
might help identify targets for radiosensitizing tumor
cells.
INTRODUCTION
Damage to DNA is considered to be the main event resulting in
cell death or mutations after ionizing radiation. Ionizing radiation
simultaneously produces different types of lesions, such as
base modifications and loss, DNA–DNA intrastrand and inter-
strand crosslinks, DNA–protein crosslinks, single-strand
breaks (SSBs) and double-strand breaks (DSBs). The pivotal
role of DSB repair after exposure to ionizing radiation by non-
homologous end joining (NHEJ) and recombinational repair
has been well documented. Numerous examples of rodent cell
lines or mice showing a defect in these repair pathways have
been reported, all exhibiting a highly radiosensitive phenotype.
This includes cells displaying a deficiency in Ku80, Ku70 and
DNA-PKcs, proteins crucial to NHEJ (1–4).
Other lesions produced by ionizing radiation, such as base
modifications, apurinic/apyrimidinic (AP) sites and SSBs,
produced either directly or secondarily by oxidative attack, are
thought to be repaired by the base excision repair (BER)
pathway (5). Studies on mice or cell lines deficient in proteins/
enzymes involved in BER have failed to show the same clear
increase in radiosensitivity as seen in DSB repair-deficient
cells. DNA glycosylases specific for different types of base
damage remove the modified bases and generate abasic sites.
There are no reports on radiosensitivity in DNA glycosylase
mutant cells. Knocking out individual glycosylases leads to a
mild or no phenotype, for example with respect to alkylating
agent sensitivity, probably explained by partial redundancy
between the different glycosylases (6–8).
During BER, AP endonucleases incise the DNA backbone at
abasic sites resulting from glycosylase action or after spontaneous
hydrolysis. One study reported increased sensitivity to γ-radiation
in AP endonuclease-deficient blastocysts (9), indicating its
role in processing radiation damage. When BER is initiated
from a SSB, PARP and XRCC1 recognize the break and poly-
nucleotide kinase (PNK) trims the ends for repair synthesis
(10). Both PARP and XRCC1 mutant cells have been shown to
display increased sensitivity to ionizing radiation (11–13). In
contrast, cells deficient in DNA polymerase β, an enzyme
considered to play an essential role in the correct restitution of
the DNA after base excision, are surprisingly not more radio-
sensitive than their wild-type counterparts (14,15). DNA
polymerase β fills the gap created by the upstream BER
enzymes, using the opposite complementary base as a template
followed by phosphodiesterase removal of the remaining
sugar–phosphate moiety (16). It has also been shown to repair
SSBs in vitro in a multiprotein complex with PNK, together
with other proteins such as XRCC1 and ligase III (17).
The DNA polymerase β protein and enzymatic activity have
been well characterized and its function and role in the repair
of alkylating damage in vitro and in vivo has been described
(16,18). This enzyme performs mainly a 1 nt gap filling reaction
in mammalian cells, termed the ‘short patch’ repair pathway of
BER (19). The minor long patch repair pathway involves
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polymerases δ/ε and proliferating cell nuclear antigen (PCNA)
(20,21) or DNA polymerase β (22). This pathway leads to a
repair synthesis of 2–10 nt. Consistent with its role in BER,
polymerase β-deficient cells show hypersensitivity to
alkylating agents like methyl methanesulfonate (MMS) and
N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) (15,23).
Considering the critical enzymatic role of DNA polymerase
β, the lack of a radiosensitive phenotype in knockouts remains
puzzling. Defining the role of BER in sensitivity to ionizing
radiation has been difficult, however, since some deletion
mutations would be lethal to the cell (e.g. polymerases δ/ε) and
the phenotype of others are affected by redundant pathways.
Husain et al. previously described a fragment of DNA
polymerase β that acts as a dominant negative inhibiting
polymerase β in vitro, probably by its specific DNA binding
properties (24). In order to clarify the role of BER in repair of
DNA damage after ionizing radiation, we introduced this 14 kDa
fragment of DNA polymerase β into two different radio-
resistant human tumor cells and tested the influence on radio-
sensitivity.
MATERIALS AND METHODS
Cell culture and cell lines
SQ20B cells isolated from human squamous cell carcinoma of
the head and neck were obtained from J. B. Little (Harvard).
SQD9 is a subclone of SQ20B and has been previously described
(25). A549 human lung carcinoma cells were provided by the
American Type Culture Collection. The amphotropic viral pack-
aging cell line Phoenix-Ampho was obtained from A. Q. Bakker
and H. Spits (Netherlands Cancer Institute) with permission of
the G. P. Nolan laboratory (Stanford). All cells were grown as
monolayers in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum, 100 U/ml penicillin and
100 µg/ml streptomycin, at 37°C in a 5% CO2 humidified
atmosphere. For growth assays, cells were plated at different
initial concentrations on 6-well plates. Cell growth curves were
determined by counting the cells daily until confluence.
Doubling times were calculated from the exponential growth
phase.
Construction of the polDN His-tagged protein-expressing
LZRS vector
The LZRS vector has been previously described (26). The
LZRS-MS-EGFP vector (a gift of J. Collard, Netherlands
Cancer Institute) is a bicistronic retroviral vector expressing
the gene of interest and the enhanced green fluorescence
protein (EGFP) cassette linked via an IRES site under the
control of the viral 3′-long terminal repeat (LTR) promotor
(27). polDN was created by PCR amplification of the sequence
corresponding to the 14 kDa N-terminal DNA-binding domain
of DNA polymerase β. The plasmid pKSpolβ (obtained from
B. Kaina, University of Mainz, Germany), a subclone of the
pMTβpol clone (28), was used for this purpose. As 5′ primer,
an oligonucleotide was synthesized containing a BamHI
restriction site and the optimal Kozak sequence GCCACC. It
included the polymerase β ATG start codon and the first 30
5′ nucleotides of the polymerase β cDNA sequence. As 3′
primer, an oligonucleotide containing a His tag sequence and a
stop codon, as well as a second restriction enzyme site for
EcoRI, was synthesized. PCR was performed using the high
fidelity Pwo DNA polymerase (Boehringer) and produced an
∼500 nt fragment that was isolated and purified by gel electro-
phoresis. The restriction enzyme sites at each end allowed liga-
tion of the polDN PCR fragment into the LZRS-MS-EGFP
vector. The resulting constructs were sequenced with the ABI
Prism Big Dye Terminator kit (Perkin Elmer) and an error-free
polDN-LZRS vector selected for transfecting cells (see below).
Transfection of the packaging cell line and transduction of
human carcinoma cells
The transduction and transfection protocols followed in principal
procedures described by the Nolan laboratory (www.stanford.edu/
group/nolan/) (26). Briefly, Phoenix amphotropic retroviral
packaging cells were transfected with LZRS or LZRS-polDN
DNA (prepared with Endofree Maxi Prep; Qiagen) by a modified
version of the calcium phosphate co-precipitation protocol
(29). The viral supernatant was harvested 48 h post-transfection
and used fresh on log phase A549 or SQD9 cells which were
then grown to confluence. Using EGFP fluorescence marker
expression, transduction efficiencies were determined by flow
cytometry (FACScan; Becton Dickinson). PolDN expression
of transduced cells was verified by western blot analysis (see
below). Cells with different levels of EGFP expression were
sorted individually into 96-well plates with a FACSTAR Plus
sorter (Becton Dickinson). Single cell clone lines were then
established. EGFP-positive cells were also bulk sorted shortly
after transduction (3–5 days) to produce a mixed cell population.
EGFP and polDN expression levels were monitored at every
passage for mixed cell populations and every second passage
for single cell clones.
Irradiation and clonogenic survival assay
Cells were plated into 6-well plates with varying cell concen-
trations and irradiated after 24 h using a 137Cs irradiation unit
with a dose rate of ∼1 Gy/min. Cells were allowed to grow for
another 10–14 days before rinsing in phosphate-buffered saline
(PBS), fixing in methanol and staining with 1% crystal violet,
as described previously (25). Surviving colonies consisting of
more than 50 cells were counted in 6–12 wells of 6-well plates
and the survival of irradiated cells normalized to the plating
efficiency of unirradiated controls. Data points on survival
curves represent the mean surviving fraction of five or six
independent experiments. In some experiments cells were
irradiated when confluent when the fraction of G1/G0 and S
cells were 80 and 10%, respectively, as determined by BrdU
labeling and flow cytometry. After an incubation of 6 h at 37°C
cells were then plated in 6-well plates and allowed to grow for
another 10–14 days before processing as mentioned above.
UV irradiation
Cells were plated into 10 cm or 6-well plates. Before irradi-
ation cells were washed with PBS and irradiated with UV light
(Stratagene UV-C bulbs, 254 nm) at a dose rate of 25 J/m2/s.
Cells were then grown in fresh medium for 10 days. After fixation
and staining, colonies consisting of more than 50 cells were
counted. Data points on survival curves represent the mean
surviving fraction of three independent experiments.
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Immunoblotting
Cell lysates were prepared in Horton buffer from logarithmic
or confluent monolayer cells. An aliquot representing 0.5 × 106
cells was resolved by 14% SDS–PAGE and transferred to
PVDF membrane using a semi-dry blot apparatus (Novablot;
Pharmacia) as recommended by the manufacturer. Blots were
incubated with either an 18S monoclonal anti-polymerase
β antibody (a generous gift from R. Prasad, NIH), which
detected polymerase β as well as the dominant negative 18 kDa
form resulting from the His-tagged 14 kDa fragment, or with
the BMG-His-1 monoclonal anti-His antibody (Boehringer).
Immunoblots were carried out with secondary antibodies
conjugated to alkaline phosphatase from Santa Cruz, detected
by the NBT/BCIP color reaction. In some experiments the BM
chemiluminescence kit (Boehringer) was used with an anti-
mouse horseradish peroxidase-conjugated secondary antibody
according to the manufacturer’s instructions.
Immunostaining
Cells were grown on CultureSlides (Falcon), fixed with 4%
formaldehyde in PBS for 10 min, permeabilized with 1% SDS
and incubated with blocking buffer containing BSA and
saponin as described previously (30). Cells were then incubated
with the monoclonal antibody to polymerase β or with the
monoclonal anti-His antibody in blocking buffer. After
washing, appropriate species-specific, TRITC-conjugated
secondary antibodies were applied as recommended by the
manufacturer (Jackson ImmunoResearch Laboratory).
Fluorescence was visualized by confocal microscopy.
Cytotoxicity assay
Cells were plated into 96-well plates and treated with MNNG
after 1 day. Cultures were stopped by removing the medium
after a further 6 (A549) or 8 (SQD9) days, before subconfluency
was reached in the untreated controls. Cells were then stained
with the fluorescent nuclear dye CyQUANT GR (Molecular
Probes) according to the manufacturer’s instructions. Fluores-
cence intensities were measured using a fluorescence micro-
plate reader (Cytofluor). Values were normalized to the
untreated controls. IC50 values were defined as the concentra-
tion of drug at which half the growth of the untreated controls
was reached. IC50 values of four to five individual experiments
were calculated.
Cell cycle phase determination
Logarithmically growing cells were pulse labeled with 1 µM
BrdU by incubating them for 10 min at 37°C. Cells were then
trypsinized, resuspended in 1 ml of PBS and fixed by adding
the cell suspension to 5 ml of ice-cold 70% ethanol. Anti-
BrdU staining was performed as described previously (31).
Briefly, nuclei were isolated by pepsin treatment, subsequently
incubated with 2 N HCl for 20 min at 37°C, neutralized with
sodium borate and washed with PBS containing Tween-20. A
mouse monoclonal anti-BrdU antibody (CLB) was used at a
1/1000 dilution for 1 h, followed by a FITC-conjugated goat
anti-mouse IgG antibody (Sigma) at a 1/50 dilution for 30 min at
room temperature. Cells were counterstained for DNA with
propidium iodide. Samples were then measured using a
FACScan flow cytometer (Becton Dickinson) and the data
analyzed with the Cell Quest software package.
Mitotic shake-off experiment
A549 cell lines were synchronized by mitotic selection (32).
Cells were seeded in T175 flasks at an appropiate density to
obtain cultures at 50–80% confluence 4 days later. Flasks were
slapped several times against the palm of the hand and the
mitotic cells were then harvested by collecting the medium and
washing the cells once with PBS. The cells were then counted
and seeded into 6-well plates containing prewarmed medium
and allowed to progress through the cell cycle under standard
growth conditions. After 4 h, at which time most of the cells
have progressed into G1, the cells were irradiated with 6 Gy.
An aliquot of the mitotic cells was grown under identical
conditions and labeled with 1 µM BrdU for 4 h to determine
the cell cycle phase distribution. In parallel, standard colony
assays were performed with exponentially growing, asynchronous
cells irradiated to 6 Gy as controls.
RESULTS
DNA polymerase β dominant negative expression
A recombinant 14 kDa N-terminal fragment (residues 1–140)
of polymerase β has been shown to be capable of binding to
both single- and double-stranded DNA but lacks DNA
polymerase activity, thus inhibiting DNA polymerase β in an
in vitro assay (24). An equivalent His-tagged fragment was
generated here by PCR and checked by sequencing, as
described in Materials and Methods. This fragment was
introduced into the human tumor cell lines SQD9 and A549 by
retroviral transduction. The bicistronic retroviral vector LZRS-
MS-EGFP, encoding EGFP as the reporter gene together with
the 14 kDa His-tagged fragment, was used to achieve high and
stable expression levels of the polDN protein. Transduction
efficiencies were high, up to 70% for A549 and 50% for SQD9
cells. EGFP expression can be rapidly monitored by flow
cytometry and allowed efficient selection of transduced cells.
Single cell sorting into individual wells of 96-well plates
allowed development of single cell clones with different EGFP
expression. PolDN expression levels of individual cell clones,
determined by western blot analysis with polyclonal and
monoclonal anti-polymerase β antibodies, correlated well with
EGFP expression levels determined by flow cytometry. Trans-
duction with LZRS or polDN expression did not change
expression of the endogenous wild-type DNA polymerase β.
Several clones with high and medium expression levels of
polDN were selected for further analysis.
Nuclear localization of 14 kDa DNA polymerase β
dominant negative
The nuclear localization signal of polymerase β has not been
described. To determine whether the 14 kDa N-terminal
domain accumulates in the nucleus we performed immuno-
fluorescence analysis using an anti-His monoclonal antibody.
Confocal images (Fig. 1) revealed the presence of punctate
nuclear staining in both polDN-transduced cell lines A549-
polDN-II-G10 (ADN-IIG10) and SQD9-polDN-II-G3
(SQDN-IIG3) with the anti-HIS antibody, in contrast to the
vector LZRS-transduced control cell lines. The intensity of
staining was higher in the polDN-transduced single cell clones
compared with the parental cell lines or controls when using a
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monoclonal antibody against polymerase β. This was expected
since the antibody recognizes the endogenous full-length
protein as well as the polDN fragment.
Dominant negative DNA polymerase β radiosensitizes
squamous cell carcinoma cells
In order to evaluate the role of base excision repair in deter-
mining radiosensitivity in tumor cell lines, we introduced the
dominant negative form in human tumor cell lines having a
radioresistant phenotype. The SQD9 cell line, a subclone
derived from the well-known SQ20B human squamous
carcinoma cell line (25), is radioresistant, with an SF2
(survival after 2 Gy) of 60% and a D10 (dose for 10% survival)
of 8 Gy. Four polDN-transduced single cell clones and two
corresponding LZRS empty vector control cell lines were
selected according to their polDN expression levels. We
observed that high levels of EGFP alone after retroviral trans-
duction led to slightly increased survival (radioprotection)
after irradiation in several independent experiments (data not
shown). The LZRS empty vector control cell clones were
therefore selected for comparable EGFP expression to their
polDN counterparts.
As shown in Figure 2B, the polDN-expressing cell clones
exhibited decreased cell survival after irradiation compared
with the empty vector control. The extent of the radiosensitiza-
tion was dependent on the amount of dominant negative expres-
sion, as determined by western blot analysis (Fig. 2D). The
calculated average dose-effect factor (DEF) at 10% survival
increased from 1.3 to 1.7 in the SQDN-IIG3 clone compared
with the SQLz-IIE2 control. To determine if the observed
differences resulted from non-specific clonal effects not
connected to polDN expression (e.g. integration locus of the
virus, other mutations), we examined the clonogenic survival in a
second triplet of single cell clones derived from an independent
transduction experiment. The same polDN dose-dependent
sensitization pattern was observed in these clones, reaching an
average DEF of 1.75 calculated at 10% survival for the highest
polDN-expressing clone (Fig. 2A). Clonogenic assays
performed by irradiating these cells in the plateau phase
confirmed the radiosensitization effect observed with survival
assays on log phase cells (DEF 1.5).
We conclude that expression of the 14 kDa N-terminal DNA
polymerase β dominant negative protein significantly
enhanced cell death after irradiation of SQD9 cells and postulate
that this could be due to interference in BER.
Radiosensitization of A549 human lung carcinoma cells
To confirm the radiosensitizing effect, we selected a second
human carcinoma line with a different genetic background.
p53 has been demonstrated to interact directly with polymerase β
and AP endonuclease, stabilizing the binding of DNA
polymerase β to abasic DNA and markedly stimulating BER
in vitro (33). The authors proposed a direct involvement of p53
as a facilitator of BER after induction through stress factors
such as γ-rays and alkylating damage. The expression of the
DNA polymerase β N-terminal domain could possibly interfere
with this interaction. We addressed this issue by choosing cell
lines with different p53 status but exhibiting a radioresistant
phenotype. Analysis of p53 status by FASAY and PCR
revealed expression of mutant p53 in SQD9 (34), whereas the
A549 cell line has been reported to have wild-type p53 expression
(35,36).
We transduced the A549 human lung carcinoma cells with
the polDN retroviral vector and generated several single cell
clones. One of these was selected (ADN-IIG10) that exhibited
comparable expression levels of polDN to the SQD9 cell line
SQDN-IIG3 (Fig. 2D). The LZRS control cell line (ALz-II-E2)
showed slightly decreased cell death compared with the
parental A549 cell line, as found previously with SQD9. This
small effect can be seen in Figure 2C (dashed line versus
closed circles). Two cell clones were therefore chosen in which
EGFP expression levels (flow cytometry) of the polDN-
expressing clone and the LZRS empty vector control cell clone
were equal. PolDN expression was also found to render the
A549 cells significantly more sensitive to irradiation (Fig. 2C).
Average DEFs were 1.7 calculated at a survival of 10%. As
both cell lines were radiosensitized by polDN to a similar
extent, this suggests that the inhibitory effect on repair was not
dependent on p53 status or tissue of origin.
Figure 1. Localization of the polDN protein. (A and C) Vector control lines
ALZ-IIE2 and SQLZ-IIE2, respectively. (B and D) polDN-expressing cells
ADN-IIG10 and SQDN-IIG3, respectively. All cells were immunostained with
anti-His antibody and visualized by confocal microscopy. Left panels display
phase contrast images corresponding to the fluorescence images on the right.
DN-transduced cell lines show nuclear expression.
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Radiosensitization of mixed cell populations
Although several single cell clones were analyzed and showed
increased cell death after irradiation, we wanted to further
exclude possible artifactual clonal effects by analyzing freshly
transduced cell populations without any clonal selection
(which we term mixed cell populations). Two days after trans-
duction with empty or polDN-containing retroviruses, SQD9
and A549 tumor cells were sorted for EGFP positivity. Irradiation
experiments were then performed as soon as possible. The use
of low passage numbers after sorting were then critical, since
EGFP and polDN expression levels decreased significantly
with every passage, with concomitant decreases in radio-
sensitization. The clonogenic survival curves shown in Figure 3
demonstrate a radiosensitizing effect of the polDN protein in
both SQD9 and A549 cells compared with their empty vector
controls. The average polDN protein expression levels in the
mixed cell population were lower than in the single cell clones,
probably explaining the lower DEFs of around 1.2. The mixed
cell population data do, however, confirm the radio-
sensitization effects observed in the single cell clones.
The effect of cell growth stage and cell cycle phase
Changes in cell growth or cell cycle phase distribution can
result in differences in radiosensitivity. It is known that cells in
G1 are generally more sensitive to irradiation than cells in S.
An increase in the relative number of G1 cells by DN expression,
due to an unknown cause, could then lead to radiosensitization;
an essentially trivial explanation. We therefore studied the cell
growth rate and the cell cycle phase distribution of A549 and
SQD9 single cell clones. As shown in Table 1, there were no
significant differences in the doubling times of polDN/EGFP-
expressing cells versus LZRS empty vector EGFP-expressing
cells. Relative numbers of cells in G1/G0, S and G2 were
determined by BrdU labeling and flow cytometry of exponentially
Figure 2. Expression of polDN radiosensitizes human carcinoma cells. Radi-
ation cell survival curves of polDN-expressing SQD9 (A and B) and A549
(C) cell clones (labeled DN) and their corresponding empty vector controls
(labeled Lz). (A) and (B) show results from two independent retroviral infec-
tions and corresponding derived independent subclones. Each point represents
the mean of five independent experiments; error bars, SD. In both series of
subclones, greater radiosensitization was seen in lines expressing higher
polDN levels. The dashed lines in (A) and (C) represent mean survival curves
for uninfected SQD9 parent (n = 5) and A549 parent (n = 13) lines, respectively.
(D) Expression of DNA polymerase β and polDN determined by western blot
analysis with an anti-DNA polymerase β antibody on cell lysates from the cell
clones shown in (B) and (C).
Figure 3. Radiosensitization of mixed cell populations (bulk sorted for high
EGFP expression). Radiation survival curves of SQD9 (top) and A549 (bottom)
human carcinoma cells transduced with empty vector (LZRS) or the dominant
negative (polDN).
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growing cells. Again, no significant differences were observed
between polDN-expressing clones compared with the empty
vector controls (Table 1). These data show that expression of
the polymerase β dominant negative did not have an impact on
normal cell growth. They also indicate that the polDN protein
did not interfere dramatically with replication, since a decrease
in doubling time or an S phase prolongation would then be
expected.
Sensitivity to UV
The cells expressing a dominant negative to polymerase β are
not expected to be more sensitive to UV irradiation. DNA
damage resulting from UVC irradiation is primarily pyrimidine
dimers that are repaired by the nucleotide excision repair
(NER) pathway, which does not involve polymerase β. No
significant difference in UVC sensitivity could be detected
between ALz-IIE2 and ADN-IIG10 cells (Fig. 4). A slight
increase in sensitivity was observed in comparison with the
parental A549 cells (dashed line in Fig. 4), although the effect
was small. These results confirm the expectation that the
presumed dominant negative of polymerase β does not inter-
fere with NER. Moreover, these data indicate, like the cell
growth studies, that dominant negative expression does not
globally affect viability in such a way that the response to any
genotoxic insult is increased.
Sensitivity to MNNG
Mouse embryonic fibroblasts deficient in DNA polymerase β
have been shown to be highly sensitive to alkylating drugs like
MNNG. This drug induces lesions repaired primarily by BER,
thus confirming the role of polymerase β in this repair pathway
(15,23). The polymerase β dominant negative is thought to
bind to glycosylase- and AP-endonuclease-treated DNA sites,
thus blocking wild-type polymerase β access. If so, we would
expect an increased sensitivity of polDN-expressing cells to
MNNG. We therefore analyzed the ADN-IIG10 and SQDN-
IIG3 clones in a 96-well cell growth assay for MNNG sensi-
tivity and compared this with their corresponding vector
controls ALz-IIE2 and SQLz-IIE2. A typical dose-response
curve is shown in Figure 5A. All curves showed a character-
istic two step pattern, with a subpopulation of cells showing
the same sensitivity as the LZRS controls. The IC50 values of
four independent experiments were calculated (Fig. 5B). A
significant increase in MNNG sensitivity was observed in the
sensitized subpopulation in both cell carcinoma lines trans-
duced with the polymerase β dominant negative, suggesting
inhibition of BER.
Lack of radiosensitization in G1-enriched populations
The two step pattern seen in the MNNG cytotoxicity assays,
and data on irradiation experiments carried out at different
growth stages, suggested a potential differential effect on
Table 1. Cell cycle phase distribution and cell growth
G1/G0, S and G2 cell proportions were determined by BrdU labeling and flow
cytometry of exponentially growing cells. The mean of the percentages of cell
cycle phases of five (A549) or three (SQD9) independent experiments are
shown with SD. Doubling times were determined as described in Materials
and Methods.
G1/G0 (%) S (%) G2 (%) Doubling time
(h)
SQLz-IIE2 30 ± 16 55 ± 15 13 ± 2 44.4
SQDN-IIG3 19 ± 14 68 ± 18 12 ± 7 43.2
ALz-IIE2 32 ± 3 57 ± 2 10 ± 3 21.8
ADN-IIG10 33 ± 8 50 ± 6 11 ± 3 22.3
Figure 4. Sensitivity to UV. UVC radiation survival curves of A549 parental
cells and the polDN-expressing ADN-IIG10 and the empty vector control
ALz-IIE2 cell clones. Each point represents the mean of three independent
experiments; error bars, SD.
Figure 5. Sensitivity to MNNG. Cells were exposed to MNNG 24 h after seeding
in 96-well plates. Cell growth was determined by a fluorescence assay after 6
or 8 days. (A) Representative growth response curves of two experiments are
shown for the SQDN-IIG10 clone. For comparison, the mean ± SD of five indi-
vidual experiments for SQLz-IIE2 vector controls are shown. (B) IC50 values
(mean ± SD) of five individual experiments for A549 (left) and SQD9 cells
(right) transduced with polDN (DN) or empty vector (Lz). For the polDN-
expressing clones, IC50 values of the sensitized subpopulation are given. DN-
expressing cells are 7–30 times more sensitive to MNNG than vector controls.
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different cell cycle phases. We therefore wished to study
radiosensitization on synchronized cells. Since we ideally
wanted to use a non-cytotoxic procedure, we chose to use
mitotic shake off. Mitotic cells collected from an exponentially
growing culture will proceed synchronously through S and G2.
At the time of irradiation, the G1 cell population was enriched
from 34% of the control to an average of 75%, with <20% S phase
cells as determined by BrdU labeling and flow cytometry. We
found that the sensitizing effect of polDN was abolished when
irradiating cells enriched for G1 using this method (Fig. 6). We
therefore conclude that the polDN sensitizing effect occurs
largely in the S and G2 phases. It should be noted that a
resistant subpopulation should be reflected in the survival
curves for asynchronous populations. Figure 2A and B is
consistent with this, although Figure 2C appears to be an
exception. Why this is is not known at present and needs
further study.
DISCUSSION
We have shown here that the expression of a 14 kDa
N-terminal fragment of DNA polymerase β (polDN) is capable
of sensitizing two different human tumor cell lines to ionizing
radiation. The magnitude of radiosensitization was dependent
on the expression level of polDN. In addition, the effects were
seen not only in individual subclones but also in mixed
populations of cells tranduced with the retroviral vector
containing the dominant negative. The LZRS vector alone
appeared to induce slight radioprotection. Several studies have
shown that LTR viral promotors bind AP1 transcription factors
(37), which can be stimulated by ionizing radiation (38).
Whether this effect on the stress response influences radio-
sensitivity or whether there is some radical scavenging effect
of EGFP is not known. Whatever the mechanism, the dominant
negative more than compensated for this small effect, causing
significant radiosensitization.
Based on the in vitro analysis by Husain et al. (24) we
hypothesized that the polDN protein consisting of the
N-terminal DNA-binding domain of polymerase β disrupts
BER by binding to specific damaged DNA (AP sites). This
will prevent the gap from being filled, since polDN lacks the
ability to catalyze DNA synthesis. Binding to the gaps will
probably also interfere with the binding of other alternative
DNA polymerases. In this way the polDN protein competes
with endogenous DNA polymerases β and δ/ε for the damage,
thereby probably inhibiting both the short and long patch
pathways. The fact that sensitization was still increasing with
increasing amount of polDN indicates that binding of polDN at
damaged sites in this dose range was probably not yet saturated. It
is therefore possible that higher radiosensitizing effects are
possible if higher levels of polDN could be achieved.
Our data suggesting interference of BER by polDN are
consistent with other studies expressing a catalytically non-
functional polymerase β mutant. A similar polymerase β dominant
negative has been used in Saccharomyces cerevisae (39,40).
The authors showed that the DNA polymerase β mutant specif-
ically interferes with the gap filling step in BER. This resulted
in sensitivity to the DNA alkylating agent MMS but not to
UV (40), indicating an involvement in BER and not in NER.
Bhattacharyya and Banerjee (41) showed that colorectal
carcinoma cells expressing a DNA polymerase β truncated
variant without the catalytic domain from one allele exhibited
substantially decreased BER activity and increased sensitivity
to MNNG.
DNA damage produced by alkylating drugs are partly
repaired by BER, as shown by the hypersensitivity to MMS
and MNNG of polymerase β- and 3-methyladenine DNA
glycosylase-deficient cells (15,23,42). The increased sensi-
tivity to MNNG of cells expressing our dominant negative
construct reported here is thus indirect evidence confirming the
mechanism and suggests inhibition of BER. However, it
should be noted that alkylated DNA is not exclusively repaired
by the BER pathway. Mismatch repair is involved in the
removal of damage resulting from alkylating agents, as demon-
strated by the increased sensitivity to MNNG of mismatch-
deficient cells (43). To date, however, cell lines deficient in
MMR and NER have not shown significant changes in survival
after ionizing radiation (44). In addition, strong binding of the
polDN protein, derived from the highly specific DNA-binding
domain of polymerase β, to possible intermediates in mismatch
repair seems unlikely.
It is clear from in vitro studies that polymerase β is important
in the repair of SSBs (17), oxidized bases (45,46) and AP sites
(47,48), the major radiation lesions in DNA apart from DSBs.
However, knocking out polymerase β has no effect on sensi-
tivity to ionizing radiation (14,15). Knockout cells may repair
such damage by using the alternative long patch BER pathway
involving PCNA-dependent DNA polymerase δ or ε. This is
supported by in vitro analyses showing an increase in long
patch repair of 8-oxoguanine in DNA polymerase β-deficient
cells (46). We propose that polDN inhibits not only the major
short patch repair pathway of BER, in which polymerase β
is a central player, but also blocks the DNA polymerase
β-independent long patch repair pathway, resulting in higher
levels of unrepaired nicked AP sites, ultimately leading to
increased radiosensitivity. Knocking out polymerase β thus
primarily eliminates the short patch pathway, leaving the long
patch pathway intact and giving the cells an escape route for
repair. The dominant negative construct on the other hand also
blocks this escape route.
Which repair pathway is predominantly used after radiation
damage is not clear. Klungland and Lindahl (22) showed that
Figure 6. Lack of radiosensitization in a G1-enriched cell population. G1-
enriched or asynchronous (exponential growing) cells of the same passage
were exposed to 6 Gy and survival determined by a clonogenic assay. Data rep-
resent the means ± SD of three independent experiments.
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repair of γ-ray induced oxidized AP sites in plasmid DNA, in
contrast to regular AP sites, required FEN-1, an enzyme
involved in long patch repair. H2O2 causes oxidation at purines
and pyrimidines, abasic sites and SSBs (49), similar to ionizing
radiation. Fortini et al. (50) showed that sensitivity to H2O2
was increased in polymerase β-deficient cells. They also
detected no differences between repair of SSB in H2O2-treated
polymerase β-deficient and normal cells, indicating
polymerase β-independent repair of the damage. Nakamura et
al. (51) demonstrated that oxidized AP sites after H2O2 are not
efficiently excised by polymerase β. These data all suggest that
ionizing radiation-induced base damage is primarily repaired
by the DNA polymerase β-independent long patch pathway,
accounting for the absence of a radiation sensitivity phenotype
in polymerase β-deficient cells.
Our data thus suggest a significant role of BER, probably via
the polymerase β-independent long patch pathway, in the
repair of radiation-induced damage that contribute to cytotoxity.
BER efficiency has been correlated with radiation sensitivity
in other studies on human normal or tumor cells. Hu et al.
showed that variants of the APE1 (AP endonuclease 1) and
XRCC1 genes were associated with ionizing radiation sensi-
tivity (52). It has also been reported that APE nuclear expression
was associated with chemo-radiotherapy resistance in head and
neck cancer (53), while others have found a correlation
between HAP1 (APE1) levels and radiosensitivity in human
cervix carcinoma (54). We observed DEFs of 1.5–1.7 here,
which compare favorably with other reported genetic modi-
fications of radiosensitivity. Dominant negative inhibition of
PARP or MEK2 achieved DEFs of 1.3 and 1.4 in Chinese
hamster (55) and HeLa cells (56), respectively. Marangoni et al.
reported DEFs of 2.0 after transfection of a dominant negative
mutant of Ku80 in CHO cells (57), while XRCC1 knockouts
showed DEFs of 1.4 (58). The increased sensitivity observed
in our DNA polymerase β dominant negative-expressing cells
is therefore consistent with biologically significant reduction
in repair of DNA damage.
The observed radiosensitization appeared to be dependent on
cell growth status and cell cycle phase. Cell populations
enriched for G1 cells of exponentially growing cultures showed
no radiosensitization, in contrast to confluent cultures (also
high in G0/G1), which exhibited radiosensitization by polDN.
There are several possible explanations. (i) Greater expression
of polymerase β in G1, for example, would compete more
effectively with polDN, although such differential expression
has not been reported (59–62). (ii) PolDN might inhibit the
short patch pathway more efficiently than alternative path-
ways, and these alternative pathways may be more pronounced
in G1. At the moment, there is little direct evidence to support
this. (iii) Translesion (TL) and recombination repair offer alter-
native pathways for repair of DNA lesions remaining after
polDN interference in BER (63). In Escherichia coli, repair of
chromosomal AP sites involves all three pathways (64). We
suggest that cells damaged in G1 that enter S phase can repair
remaining damage through TL or recombination. Cells exhibiting
a dominant negative effect have probably already replicated
their DNA and will not be able to use the TL repair pathway.
This is consistent with our MNNG data showing a subpopulation
of cells with normal sensitivity, indicating that unrepaired
alkylating damage, probably consisting of nicked AP sites, can
also be repaired through TL or recombinational repair.
Confluent cells do not enter replication within the first hours of
repair after irradiation, precluding this repair route. A similar
conclusion was made by Taylor et al., who stated that S phase
DNA repair processes can remove strand breaks induced in
S phase and those that persist from G1 and can in part compensate
for lack of repair in G1 (65).
In summary, the results suggest that the polymerase β dominant
negative construct radiosensitized human tumor cells by inter-
fering with BER due to binding to gapped DNA, thus blocking
appropriate repair enzymes. In contrast to polymerase β-deficient
cells, the dominant negative efficiently interfered with BER of
ionizing radiation-damaged DNA, most probably due to
additional blocking of the alternative long patch repair
pathway involving polymerases δ and ε. These studies support
an important role for BER in determining radiosensitivity and
suggest potential applications in diagnosis and possibilities to
modulate radiosensitivity of tumor cells in radiotherapy.
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